Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jun;23(6):639-640.
doi: 10.1016/S1473-3099(23)00056-7. Epub 2023 Feb 10.

Real-world effectiveness of nirmatrelvir-ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants

Carlos K H Wong  1 , Kristy T K Lau  2 , Gabriel M Leung  3
Affiliations
Comment

Real-world effectiveness of nirmatrelvir-ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants

Carlos K H Wong et al. Lancet Infect Dis. 2023 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

References

    1. Aggarwal NR, Molina KC, Beaty LE, et al. Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study. Lancet Infect Dis. 2023 doi: 10.1016/S1473-3099(23)00011-7. published online Feb 10. - DOI - PMC - PubMed
    1. Amani B, Amani B. Efficacy and safety of nirmatrelvir/ritonavir (paxlovid) for COVID-19: a rapid review and meta-analysis. J Med Virol. 2022;95 - PMC - PubMed
    1. Cheema HA, Jafar U, Sohail A, et al. Nirmatrelvir–ritonavir for the treatment of COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2023;95 - PubMed
    1. Zheng Q, Ma P, Wang M, et al. Efficacy and safety of paxlovid for COVID-19: a meta-analysis. J Infect. 2023;86:66–117. - PMC - PubMed
    1. Schwartz KL, Wang J, Tadrous M, et al. Real-world effectiveness of nirmatrelvir/ritonavir use for COVID-19: a population-based cohort study in Ontario, Canada. medRxiv. 2022 doi: 10.1101/2022.11.03.22281881. published online Nov 5. (preprint). - DOI

Supplementary concepts